Nutraceuticals company HealFast Inc announces the development of a turnkey distribution model for all partnering physicians offering its Surgical & Injury Recovery Support Program in North America.
Adding to a previous deal on dermatological products, Swedish firm Karo Pharma has now acquired a focused intimate care and dermatology product portfolio from privately-held Danish firm LEO Pharma for 90 million euros ($99.8 million), thepharmaletter.com reports.Read More
The Opioid-Prescribing in Dermatology Workgroup determined that 10% of patients or less undergoing 87 common dermatological procedures require postoperative opioid management at discharge, according to Healio.Read More
Two doses of Novartis’ new treatment for chronic hives cleared the skin of more patients than Xolair, its Roche-partnered asthma drug that scored approval for the skin condition in 2014, FierceBiotech reports.Read More
Among topical dermatologic drugs, the mean overpayment for brand-name drugs was more than double that of generics, based on an analysis of claims data of privately insured individuals published in JAMA Dermatology.Read More